ZyVersa Therapeutics, Inc. (ZVSA)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Oct 19, 2026
ZyVersa Therapeutics Market Cap
ZyVersa Therapeutics has a market cap or net worth of $8.1 thousand as of October 20, 2026. It is the 51,880th most valuable company in the world and the 7,896th biggest in the United States. Its market cap has decreased by 99.29% in one year.
Market Cap
8.10K
Enterprise Value
905.44K
Revenue
n/a
Global Rank
Country Rank
#7,896 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since February 10, 2022, ZyVersa Therapeutics's market cap has decreased from 95.47M to 8.10K, a decrease of -99.99%. That is a compound annual growth rate of -86.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 388.60K | -64.07% |
| Dec 31, 2025 | 1.08M | -59.32% |
| Dec 31, 2024 | 2.66M | -43.66% |
| Dec 29, 2023 | 4.72M | -66.90% |
| Dec 30, 2022 | 14.26M | -85.07% |
| Feb 10, 2022 | 95.47M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innoveren Scientific | 2.40K |
| OncoVista Innovative Therapies | 2.36K |
| Lipella Pharmaceuticals | 2.31K |
| Suvanza Pharma, LLC | 2.24K |
| RegeneRx Biopharmaceuticals | 1.66K |
| ZIM Corporation | 1.63K |
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |